Keros Therapeutics adjusts TROPOS trial of cibotercept amid safety concerns

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, has announced significant changes to its Phase 2 TROPOS trial evaluating cibotercept safety concerns in patients with pulmonary ... Read More